Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.17 USD | +5.55% | -6.38% | -5.59% |
03/05 | B. Riley Adjusts Xponential Fitness Price Target to $31 From $28, Maintains Buy Rating | MT |
02/05 | Earnings Flash (XPOF) XPONENTIAL FITNESS Posts Q1 Revenue $79.5M, vs. Street Est of $78.8M | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 488.5 | 632.1 | 398.2 | 384.4 | - | - |
Enterprise Value (EV) 1 | 598.1 | 761.4 | 398.2 | 754.7 | 698.1 | 631.7 |
P/E ratio | -7.17 x | -26.4 x | -29.3 x | 22.4 x | 8.87 x | 7.01 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 3.15 x | 2.58 x | 1.25 x | 1.11 x | 1.01 x | 0.92 x |
EV / Revenue | 3.86 x | 3.11 x | 1.25 x | 2.18 x | 1.83 x | 1.51 x |
EV / EBITDA | 21.9 x | 10.3 x | 3.78 x | 5.51 x | 4.37 x | 3.41 x |
EV / FCF | 55.3 x | 17.8 x | - | 11.8 x | 7.65 x | 5.88 x |
FCF Yield | 1.81% | 5.61% | - | 8.46% | 13.1% | 17% |
Price to Book | -0.7 x | -7.29 x | - | -6.21 x | -14.8 x | -34.8 x |
Nbr of stocks (in thousands) | 23,898 | 27,566 | 30,891 | 31,584 | - | - |
Reference price 2 | 20.44 | 22.93 | 12.89 | 12.17 | 12.17 | 12.17 |
Announcement Date | 03/03/22 | 02/03/23 | 29/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 106.6 | 155.1 | 245 | 318.7 | 346.2 | 380.5 | 418.6 |
EBITDA 1 | - | 27.32 | 74.25 | 105.3 | 137 | 159.8 | 185.2 |
EBIT 1 | - | -30.82 | 15.14 | 39.67 | 80.35 | 123.6 | 147.8 |
Operating Margin | - | -19.87% | 6.18% | 12.45% | 23.21% | 32.48% | 35.32% |
Earnings before Tax (EBT) 1 | - | -50.66 | 3.401 | -0.642 | 36.01 | 85.61 | 109.7 |
Net income 1 | -13.64 | -18.83 | - | -0.903 | 28.49 | 75.44 | 69.55 |
Net margin | -12.8% | -12.14% | - | -0.28% | 8.23% | 19.83% | 16.62% |
EPS 2 | - | -2.850 | -0.8700 | -0.4400 | 0.5433 | 1.372 | 1.735 |
Free Cash Flow 1 | - | 10.81 | 42.72 | - | 63.87 | 91.26 | 107.4 |
FCF margin | - | 6.97% | 17.44% | - | 18.45% | 23.98% | 25.66% |
FCF Conversion (EBITDA) | - | 39.57% | 57.53% | - | 46.63% | 57.1% | 57.99% |
FCF Conversion (Net income) | - | - | - | - | 224.19% | 120.97% | 154.42% |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 03/06/21 | 03/03/22 | 02/03/23 | 29/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 49.37 | 50.36 | 59.56 | 63.76 | 71.27 | 70.69 | 77.34 | 80.44 | 90.2 | 79.52 | 83.54 | 86.74 | 96.91 | 88.3 | 93.16 |
EBITDA 1 | 8.603 | 14.45 | 17.64 | 20 | 22.16 | 22.87 | 25.25 | 26.52 | 30.68 | 29.83 | 33.17 | 35.93 | 38.23 | 35.76 | 39.47 |
EBIT 1 | -26.92 | -14.77 | 36.14 | -10.43 | 2.566 | -7.207 | 36.45 | 7.478 | 2.949 | 7.388 | 20.71 | 24.14 | 27.75 | 27.68 | 31.33 |
Operating Margin | -54.52% | -29.34% | 60.68% | -16.36% | 3.6% | -10.2% | 47.13% | 9.3% | 3.27% | 9.29% | 24.8% | 27.84% | 28.64% | 31.35% | 33.63% |
Earnings before Tax (EBT) 1 | -29.39 | -17.25 | 33.69 | -13.36 | 0.317 | -15.1 | 27.66 | -4.981 | -8.216 | -4.403 | 10.68 | 13.22 | 16.15 | 18.15 | 21.1 |
Net income 1 | -14.77 | -7.519 | 16.83 | -13.06 | -0.247 | -9.983 | 18.38 | -3.382 | -5.917 | -2.867 | 9.263 | 11.5 | 15.93 | 14.92 | 17.08 |
Net margin | -29.92% | -14.93% | 28.26% | -20.48% | -0.35% | -14.12% | 23.76% | -4.2% | -6.56% | -3.61% | 11.09% | 13.25% | 16.44% | 16.9% | 18.33% |
EPS 2 | -2.450 | -1.510 | 0.5000 | -1.530 | -1.130 | -1.380 | 0.0900 | -0.5000 | -0.2800 | -0.3000 | 0.1775 | 0.2250 | 0.3025 | 0.3200 | 0.3500 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 03/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 02/03/23 | 04/05/23 | 03/08/23 | 07/11/23 | 29/02/24 | 02/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | 110 | 129 | - | 370 | 314 | 247 |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 4.012 x | 1.741 x | - | 2.703 x | 1.963 x | 1.335 x |
Free Cash Flow 1 | - | 10.8 | 42.7 | - | 63.9 | 91.3 | 107 |
ROE (net income / shareholders' equity) | - | - | - | - | - | 510% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | -29.20 | -3.140 | - | -1.960 | -0.8200 | -0.3500 |
Cash Flow per Share 2 | - | 0.6500 | 2.040 | - | 0.0300 | 0.0400 | - |
Capex 1 | - | 3.64 | 8.96 | 7.43 | 9.73 | 12.5 | 10 |
Capex / Sales | - | 2.35% | 3.66% | 2.33% | 2.81% | 3.28% | 2.39% |
Announcement Date | 03/06/21 | 03/03/22 | 02/03/23 | 29/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.59% | 384M | |
-16.95% | 5.28B | |
+4.23% | 2.96B | |
-1.99% | 2.94B | |
+4.40% | 1.54B | |
-24.01% | 1.5B | |
+15.18% | 447M | |
0.00% | 339M | |
+15.17% | 337M | |
-5.69% | 285M |
- Stock Market
- Equities
- XPOF Stock
- Financials Xponential Fitness, Inc.